InnoGI Technologies is a leading Contract Research Organization on a mission: to lead the way in sustainable oral drug and nutritional research and development through advanced gastrointestinal (GI) modeling. With over 30 years of experience in GI modeling, the company continues to innovate and develop the most predictive gut models. Their technologies, including the renowned TIM 1 and TIM 2 models, are used worldwide by pharmaceutical and food companies, including the US FDA.
InnoGI Technologies
At InnoGI Technologies, they provide innovative services to the pharmaceutical and food industries, specializing in gastrointestinal (GI) modeling. Their advanced in vitro models simulate the entire human GI tract, offering deep, data-driven insights into digestion, absorption, and microbiome interaction.
By delivering predictive, physiologically relevant results, they help client partners to better understand how their products behave during digestion including drug delivery, nutrient absorption, and microbiome modulation, all without the need for animal testing
